|
|
|
Insider
Information: |
Mcgaughy R Kent Jr |
Relationship: |
10% Owner |
City: |
Dallas |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
4,895,473 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$41,977,210 |
|
|
Total
Shares |
4,895,473 |
|
|
Total
Value |
$41,977,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
125.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Reata Pharmaceuticals Inc |
RETA |
|
2023-09-26 |
0 |
2023-09-26 |
0 |
Premium* |
|
Apollo Endosurgery, Inc |
APEN |
|
2016-12-29 |
0 |
2022-12-28 |
4,197,721 |
Premium* |
|
Procept Biorobotics Corp |
PRCT |
10% Owner |
|
0 |
2021-09-14 |
697,752 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
APEN |
Apollo Endosurgery, Inc |
Director |
|
2016-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
817,804 |
195,330 |
0 |
- |
|
APEN |
Apollo Endosurgery, Inc |
Director |
|
2017-07-25 |
4 |
B |
$5.50 |
$2,499,998 |
I/I |
454,545 |
469,100 |
2.1 |
- |
|
APEN |
Apollo Endosurgery, Inc |
|
|
2020-01-02 |
4 |
A |
$0.00 |
$0 |
I/I |
57,163 |
507,208 |
0 |
- |
|
APEN |
Apollo Endosurgery, Inc |
|
|
2020-07-17 |
4 |
B |
$1.25 |
$2,225,000 |
I/I |
1,780,000 |
1,707,208 |
0.01 |
% |
|
APEN |
Apollo Endosurgery, Inc |
|
|
2021-10-15 |
4 |
B |
$7.75 |
$5,300,000 |
I/I |
683,871 |
2,151,209 |
0.01 |
% |
|
APEN |
Apollo Endosurgery, Inc |
|
|
2022-12-28 |
4 |
OE |
$3.25 |
$7,145,629 |
I/I |
2,198,655 |
3,687,781 |
0 |
- |
|
PRCT |
Procept Biorobotics Corp |
10% Owner |
|
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
697,752 |
|
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-01 |
4 |
B |
$13.42 |
$107,829 |
I/I |
8,035 |
370,557 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-01 |
4 |
B |
$11.43 |
$3,194,224 |
I/I |
251,553 |
362,522 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
118,579 |
110,969 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-01 |
4/A |
B |
$11.00 |
$8,822,000 |
I/I |
802,000 |
912,969 |
2.64 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,004 |
25,004 |
0 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-06 |
4 |
B |
$17.56 |
$351,192 |
I/I |
20,000 |
390,557 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-07 |
4 |
B |
$17.62 |
$74,360 |
I/I |
4,220 |
394,777 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-24 |
4 |
B |
$18.35 |
$992,334 |
I/I |
51,435 |
446,212 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-27 |
4 |
B |
$19.17 |
$421,234 |
I/I |
21,968 |
468,180 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-28 |
4 |
B |
$19.74 |
$17,763 |
I/I |
900 |
469,080 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-29 |
4 |
B |
$19.83 |
$1,263,056 |
I/I |
63,700 |
532,780 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-06-30 |
4 |
B |
$19.75 |
$1,975,110 |
I/I |
100,000 |
632,780 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-08-16 |
4 |
B |
$16.21 |
$949,953 |
I/I |
58,600 |
1,493,380 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-08-17 |
4 |
B |
$17.26 |
$2,486,816 |
I/I |
144,058 |
1,637,438 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-08-18 |
4 |
B |
$17.32 |
$1,828,651 |
I/I |
105,562 |
1,743,000 |
0.01 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-12-14 |
4 |
B |
$21.37 |
$132,229 |
I/I |
6,189 |
1,749,189 |
2.64 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-12-15 |
4 |
B |
$22.05 |
$59,534 |
I/I |
2,700 |
1,751,889 |
2.64 |
- |
|
RETA |
Reata Pharmaceuticals Inc |
|
|
2016-12-16 |
4 |
B |
$22.99 |
$3,787,820 |
I/I |
164,753 |
1,916,642 |
2.64 |
- |
|
42 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|